Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
New drug combo tested to fight back against Tough-to-Treat blood cancer
Disease control CompletedThis study tested whether adding a drug called daratumumab to a standard two-drug therapy (pomalidomide and dexamethasone) works better for people with multiple myeloma that has come back or stopped responding to treatment. It involved 304 adults whose cancer had progressed after…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Apr 04, 2026 06:50 UTC
-
New drug tested for Tough-to-Treat blood disorder
Disease control CompletedThis study tested an experimental drug called belantamab mafodotin in 35 adults whose AL amyloidosis had returned or stopped responding to previous treatments. AL amyloidosis is a serious condition where abnormal proteins build up and damage organs like the heart and kidneys. The…
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC